Inter doctor provides update on Icardi, De Vrij and Nainggolan

22 March at 20:00
Piero Volpi, Inter Milan's medical doctor, has spoken at the Inter Medical Meeting, with quotes noted by fcinternews.it. Volpi spoke about Argentine forward Mauro Icardi; as well as revealing more about the situations around Stefan de Vrij and Radja Nainggolan.

"Icardi? Mauro is better, now he can partake in a complete activity in training with the group and partly individually to acquire a complete level of physical condition. He has not participated in 30-35 days of training with the group and must reacquire the fitness, if, in the next few days, this program is complete, he can then rejoin the group. Now he is undergoing a recovery program like all the players who have had an injury, it is not a particular thing specific to Icardi.

"Icardi available for Lazio? This is a difficult question, to which I cannot give a definite answer. There are possibilities, we will see if in the week everything that takes place on a daily basis. It will no longer depend on me, but also on the evaluations of an athletic and technical form that the staff will have to do.

"For de Vrij we have news of fatigue, which the Dutch national doctor immediately pointed out to us and, from the findings, does not seem to be anything more serious. Nainggolan is proceeding with his recovery, along the same lines as Icardi, he is completing a mixed routine and, when he's ready we'll give him to the club. We will see next week if he is ready."


For more news, views and features, visit our homepage.
 

Comments

comments powered by Disqus

More news about...

Inter
Lazio
 

Calciomercato.com ha aggiornato la propria Privacy Policy in funzione della nuova legge europea, la General Data Protection Regulation (GDPR).

Questo sito utilizza cookie, anche di terze parti, per inviarti pubblicità e servizi in linea con le tue preferenze. Se vuoi saperne di più o negare il consenso a tutti o ad alcuni cookie.

Scorrendo la pagina o cliccando il pulsante "ho capito" acconsenti all'uso dei cookie e accetti la privacy policy.